Related Experiment Video
Updated: Aug 2, 2026
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study
L A Piazza1, J C Markowitz, J H Kocsis
1Department of Psychiatry, Cornell University Medical College, New York, NY 10021, USA.
The American Journal of Psychiatry
|December 16, 1997
Summary
Selective serotonin reuptake inhibitors (SSRIs) improved sexual desire and arousal in women with chronic depression. However, men experienced worsened orgasm function, suggesting a potential medication side effect.
Area of Science:
- Psychiatry
- Pharmacology
- Sexual Medicine
Background:
- Chronic depression affects both men and women, impacting overall well-being.
- Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depressive disorders.
- Sexual dysfunction is a recognized comorbidity and potential side effect associated with depression treatment.
Purpose of the Study:
- To evaluate the effects of SSRI treatment on depression and sexual functioning in chronically depressed individuals.
- To compare changes in sexual functioning between men and women undergoing SSRI therapy.
Main Methods:
- Prospective study involving 25 subjects (14 women, 11 men) with dysthymia or chronic major depression.
- Participants received 6 weeks of treatment with sertraline or paroxetine.
- Sexual functioning and depression severity were assessed using the Arizona Sexual Experience Scale and Hamilton Depression Rating Scale.
Main Results:
- Women showed significant improvements in sexual desire, psychological arousal, and overall sexual functioning.
- Men experienced significant worsening in orgasm delay, orgasm satisfaction, and overall sexual functioning.
- Depression scores were not detailed in this abstract excerpt.
Conclusions:
- SSRI treatment may resolve sexual desire and arousal issues in depressed women.
- Orgasmic dysfunction in men following SSRI treatment could indicate a medication-induced side effect.
- Further research is warranted to differentiate between depression-related sexual dysfunction and medication side effects.
More Related Videos
04:22Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...